Literature DB >> 839412

Interpretation of plasma concentration-time curves after oral dosing.

R A Ronfeld, L Z Benet.   

Abstract

The pharmacokinetic information obtained after oral administration is examined using the two-compartment model. Data were obtained by simulation and experimentally by administering sulfisoxazole by an exponential infusion to rabbits. When the absorption rate constant is allowed to approach alpha, a typical two-compartment oral absorption curve is obtained, which is described by a triexponential equation. However, if the absorption rate constant approaches E2 (the sum of the elimination rate constants out of the peripheral compartment), the data are adequately fit by a one-compartment model, with the calculated absorption rate equal to alpha. The relative error in using a one-compartment model to calculate absorption rate constants for two-compartment data is also evaluated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839412     DOI: 10.1002/jps.2600660211

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  All half-lives are wrong, but some half-lives are useful.

Authors:  J G Wright; A V Boddy
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

Review 3.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

4.  Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF).

Authors:  M N Martinez; A J Jackson
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

5.  Pitfalls in pharmacokinetic multicompartment analysis.

Authors:  E Liang; H Derendorf
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

6.  Modeling of subcutaneous absorption kinetics of infusion solutions in the elderly using technetium.

Authors:  M S Roberts; S Lipschitz; A J Campbell; S Wanwimolruk; E G McQueen; M McQueen
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

7.  Effect of renal impairment on distribution of ofloxacin.

Authors:  A Sanchez Navarro; J Martinez Lanao; M M Sanchez Recio; A Domínguez-Gil Hurlé; J M Tabernero Romo; J C Gomez Sanchez; M M Terreiro Delgado
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

8.  Methaqualone pharmacokinetics after single- and multiple-dose administration in man.

Authors:  R K Nayak; R D Smyth; J H Chamberlain; A Polk; A F DeLong; T Herczeg; P B Chemburkar; R S Joslin; N H Reavey-Cantwell
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

9.  Compartmental modelling based on methionine tolerance test data: a case study.

Authors:  R F Brown; K R Godfrey; A Knell
Journal:  Med Biol Eng Comput       Date:  1979-03       Impact factor: 2.602

10.  Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine.

Authors:  M Schäfer-Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.